Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Impairment Renal Functions
Status:
Completed
Trial end date:
2020-08-18
Target enrollment:
Participant gender:
Summary
A Clinical Study Comparatively Evaluating the Pharmacokinetics, Pharmacodynamics and Safety
of Intravenous Administration of HSK3486 Injectable Emulsion in Patients with Chronic Renal
Impairment and Subjects with Normal Renal Functions
Phase:
Phase 1
Details
Lead Sponsor:
Sichuan Haisco Pharmaceutical Group Co., Ltd Sichuan Haisco Pharmaceutical Group Co., Ltd.
Collaborator:
The First Affiliated Hospital of Zhengzhou University